Daniel Lynch insider trades
Open-market stock purchases and sales by Daniel Lynch, Director at SpringWorks Therapeutics, Inc, from SEC Form 4 filings since Sep 25, 2013.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- SWTX SpringWorks Therapeutics, Inc: 6 sales, last Jul 1, 2025
- TSVT 2seventy bio, Inc: other filings, last Jun 13, 2023
- BLUE bluebird bio, Inc: 51 sales, last Nov 11, 2021
- BPMC Blueprint Medicines Corp: 18 sales, last Jun 24, 2020
- TBIO Translate Bio, Inc: other filings, last Jun 16, 2020
- SURF Surface Oncology, Inc: other filings, last Jun 10, 2020
- SESN Sesen Bio, Inc: other filings, last Jun 19, 2019
- EBIO Eleven Biotherapeutics, Inc: other filings, last May 19, 2017
- BIND Dnib Unwind, Inc: other filings, last Aug 26, 2016